ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0764

Frequency of large vessel vasculitis in giant cell arteritis with and without adventiitis of temporal artery – Is the presence of temporal arteritis sufficient to diagnose giant cell arteritis?-

Yoichiro Akiyama, Jun Nakamura, Ayako Kokuzawa, Hiroi Kusaka, Sho Tani, Fuminori Taniguchi, Kohei Morikawa, Haruka Kondo, Shotaro Yamamoto, Yasuyuki Kamata and Kojiro Sato, Jichi Medical University, Shimotsuke, Tochigi, Japan

Meeting: ACR Convergence 2025

Keywords: classification criteria, giant cell arteritis, Takayasu.s arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0731–0764) Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Takayasu arteritis (TAK) and giant cell arteritis (GCA) belong to the large vessel vasculitis group. Differences between the two diseases have been reported based on age, clinical presentation, and HLA. ACR/EULAR classification criteria for GCA have been reported, but no pathological criteria for the temporal artery (TA) have been proposed. Pathologically, inflammation of the aorta in TAK starts from the adventitia and inflammation of the temporal artery (TA) in GCA starts from the tunica media, indicating different sites of inflammation in the two diseases. Therefore, it is important to classify TAK and GCA based on pathological findings rather than distinguishing between them based on age. In this study, it was examined whether there is a difference in the presence or absence of aortitis depending on the site of inflammation of the TA (presence or absence of adventitial inflammation) in cases diagnosed with GCA.

Methods: The study included patients admitted to our hospital from 2004 to 2023, who underwent temporal artery biopsy (TAB) and contrast-enhanced thoraco-abdominal computed tomography, and were diagnosed with GCA. According to the pathology of the TAB, the patients were divided into two groups: those with (Ad+ group) and without (Ad- group) adventitial inflammation. In those two groups, clinical symptoms, laboratory findings, and the presence of aortitis were compared between the groups.

Results: Thirty-two patients were included in the study, 21 in the Ad+ group and 11 in the Ad- group. The median age in the Ad+ and Ad- groups was 73 and 69 years, respectively (p=0.010), the frequency of clinical findings were as follows: fever (52.4% vs. 36.4%, p=0.472), headache (81.0% vs. 90.9%, p=0.637), polymyalgia rheumatica (PMR) symptoms (23.8% vs. 36.4%, p=0.681), and TA symptoms (42.9% vs. 81.8%, p=0.061). Blood test findings (median values) showed no significant differences in WBC (7,900 /µl vs. 7,800 /µl, p=0.984) or CRP (9.60 mg/dl vs. 9.26 mg/dl, p=0.736); however, ALP levels in Ad+ group were lower than those in the Ad- group (244 U/L vs. 446 U/L, p=0.009). The frequency of aortitis in the Ad+ group was significantly higher than in the Ad- group (81.0% vs. 27.3%, p=0.006). The initial dose of glucocorticoid (GC) tended to be higher in the Ad+ group (1.0 mg/kg vs. 0.6 mg/kg, p=0.066).

Conclusion: In this study, the Ad- group may have true GCA and the Ad+ group may have TAK; it may be important to distinguish between GCA and TAK based on TAB pathology rather than age.


Disclosures: Y. Akiyama: None; J. Nakamura: None; A. Kokuzawa: None; H. Kusaka: None; S. Tani: None; F. Taniguchi: None; K. Morikawa: None; H. Kondo: None; S. Yamamoto: None; Y. Kamata: None; K. Sato: None.

To cite this abstract in AMA style:

Akiyama Y, Nakamura J, Kokuzawa A, Kusaka H, Tani S, Taniguchi F, Morikawa K, Kondo H, Yamamoto S, Kamata Y, Sato K. Frequency of large vessel vasculitis in giant cell arteritis with and without adventiitis of temporal artery – Is the presence of temporal arteritis sufficient to diagnose giant cell arteritis?- [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/frequency-of-large-vessel-vasculitis-in-giant-cell-arteritis-with-and-without-adventiitis-of-temporal-artery-is-the-presence-of-temporal-arteritis-sufficient-to-diagnose-giant-cell-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frequency-of-large-vessel-vasculitis-in-giant-cell-arteritis-with-and-without-adventiitis-of-temporal-artery-is-the-presence-of-temporal-arteritis-sufficient-to-diagnose-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology